 Amgen Inc NASDAQ: AMGN has agreed to acquire Five Prime Therapeutics Inc NASDAQ: FPRX for 38 per share in cash, representing an equity value of approximately 1.9 billion. The offer price of 38 represents a whopping 79 premium on the last close price of 21.26 on Wednesday. 